Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,398,553 papers from all fields of science
Search
Sign In
Create Free Account
Progression-Free Survival
Known as:
Progression Free Survival
, PFS
, Progression-Free Survivals
Expand
The length of time during and after treatment in which a patient is living with a disease that does not get worse. Progression-free survival may be…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Disease-Free Survival
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord…
D. Rades
,
M. Lange
,
+5 authors
S. Schild
International Journal of Radiation Oncology…
2009
Corpus ID: 10351556
Highly Cited
2007
Highly Cited
2007
VELCADE/Dexamethasone (Vel/D) Versus VAD as Induction Treatment Prior to Autologous Stem Cell Transplantion (ASCT) in Newly Diagnosed Multiple Myeloma (MM): Updated Results of the IFM 2005/01 Trial.
J. Harousseau
,
C. Mathiot
,
+7 authors
P. Moreau
2007
Corpus ID: 208485345
Introduction. ASCT is considered the standard of care for younger patients (pts) with MM. The benefit of ASCT is at least partly…
Expand
Review
2006
Review
2006
Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
B. Monk
,
E. Han
,
Carol A. Josephs-Cowan
,
Gordon Pugmire
,
R. Burger
2006
Corpus ID: 73295685
Highly Cited
2005
Highly Cited
2005
Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma
A. Lin
,
N. Brophy
,
+4 authors
L. Levitt
Cancer
2005
Corpus ID: 24612091
The hypervascular nature of hepatocellular carcinoma (HCC) is well characterized. Recent data have suggested that thalidomide…
Expand
Highly Cited
2003
Highly Cited
2003
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413
J. Smith
2003
Corpus ID: 58162865
Highly Cited
2000
Highly Cited
2000
Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
J. Cheng
,
V. Chuang
,
+9 authors
C. Horng
International Journal of Radiation Oncology…
2000
Corpus ID: 7521654
Highly Cited
1999
Highly Cited
1999
Low-Loss Passive Optical Waveguides Based on Photosensitive Poly(pentafluorostyrene-co-glycidyl methacrylate)
C. Pitois
,
S. Vukmirovic
,
A. Hult
,
D. Wiesmann
,
M. Robertsson
1999
Corpus ID: 18685217
Low-loss optical waveguides have been fabricated from fluorinated copolymers designed to incorporate photochemical amplification…
Expand
Highly Cited
1998
Highly Cited
1998
Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice.
C. Amling
,
M. Blute
,
S. Lerner
,
E. Bergstralh
,
D. Bostwick
,
H. Zincke
Mayo Clinic proceedings
1998
Corpus ID: 24863083
Review
1993
Review
1993
Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
M. Hazuka
,
A. Turrisi
,
+5 authors
S. Lichter
International Journal of Radiation Oncology…
1993
Corpus ID: 11973441
Highly Cited
1987
Highly Cited
1987
Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome
T. Ahles
,
M. Yunus
,
A. Masi
Pain
1987
Corpus ID: 25083868
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE